Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

vTv Therapeutics Inc. Class A Common Stock (VTVT)

Pharmaceutical Preparations

https://www.vtvtherapeutics.com

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for diabetes. The company lead program is TTP399, an orally administered, small molecule, liver-selective glucokinase activator (GKA) that is a potential adjunctive therapy to insulin for the treatment of type 1 diabetes.

3980 PREMIER DR, SUITE 310
HIGH POINT, NC

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/30/2015

Market Cap

32,916,596

Shares Outstanding

2,040,000

Weighted SO

2,037,090

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ZURA --.--%

APGN --.--%

PHIO --.--%

EFTR --.--%

IMMX --.--%

SGTX --.--%

NBY --.--%

INM --.--%

GOVX --.--%

Beta

0.6460

Last Div

0.0000

Range

7.38-30.99

Chg

0.0400

Avg Vol

23246

Mkt Cap

32916596

Exch

NASDAQ

Country

US

Phone

336 841 0300

DCF Diff

9.2532

DCF

4.2768

Div Yield

0.0000

P/S

33.2155

EV Multiple

0.5131

P/FV

5.2588

Div Yield %

0.0000

P/E

-4.2939

PEG

-0.1674

Payout

0.0000

Current Ratio

6.6142

Quick Ratio

6.6142

Cash Ratio

6.5177

DSO

112.7043

DIO

0.0000

Op Cycle

112.7043

DPO

27541.2778

CCC

-27428.5734

Gross Margin

0.9092

Op Margin

-24.3623

Pretax Margin

-23.6357

Net Margin

-20.3602

Eff Tax Rate

0.2311

ROA

-0.4343

ROE

6.3841

ROCE

-0.6116

NI/EBT

0.8614

EBT/EBIT

0.9702

EBIT/Rev

-24.3623

Debt Ratio

0.0055

D/E

0.0155

LT Debt/Cap

0.0048

Total Debt/Cap

0.0153

Int Coverage

-8047.6667

CF/Debt

-85.2031

Equity Multi

2.8199

Rec Turnover

3.2386

Pay Turnover

0.0133

Inv Turnover

0.0000

FA Turnover

3.8411

Asset Turnover

0.0213

OCF/Share

-3.4063

FCF/Share

-3.4063

Cash/Share

7.1096

OCF/Sales

-22.0101

FCF/OCF

1.0000

CF Coverage

-85.2031

ST Coverage

-123.2316

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

5.2588

P/B

5.2588

P/S

33.2155

P/E

-4.2939

P/FCF

-1.5091

P/OCF

-3.9721

P/CF

-3.9721

PEG

-0.1674

P/S

33.2155

EV Multiple

0.5131

P/FV

5.2588

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation